FzioMed, Inc. Product Pipeline Analysis

SUMMARY

FzioMed, Inc. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a FzioMed, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List Of Tables 5
1.2 List of Figures 6
2 Company Overview 7
2.1 Key Information 7
3 Major Products and Services 8
3.1 Overview 8
4 Competitors 9
5 Key Employees 10
6 Locations And Subsidiaries 11
6.1 Head Office 11
7 Recent Developments 12
7.1 Product News 12
7.1.1 Jul 17, 2008: FzioMed, Inc. Disagrees With Advisory Panel's Recommendation To FDA Regarding Oxiplex Gel 12
7.1.2 Jun 17, 2008: FzioMed Awaits FDA Panel Meeting On Oxiplex/SP Gel Approval 12
7.1.3 Mar 03, 2008: FzioMed Announces Approval Of Oxiplex Gel For Spine Surgery In Canada 12
7.1.4 Oct 13, 2006: Independent Studies On FzioMed's Anti-Adhesion Gel Presented At Spine Meetings 12
7.1.5 May 09, 2006: FzioMed Reports Promising Results Using Oxiplex Gel To Reduce Perivascular Adhesions In Preclinical Artificial Disc Surgery 13
7.1.6 Feb 05, 2001: FzioMed Inc. Announces Initiation Of Clinical Trial For Oxiplex Adhesion Prevention Product In Spine Surgery 13
7.2 Product Approvals 14
7.2.1 Mar 03, 2008: FzioMed Announces Approval Of Oxiplex Gel For Spine Surgery In Canada 14
7.3 Clinical Trials 14
7.3.1 Oct 13, 2006: Independent Studies On FzioMed's Anti-Adhesion Gel Presented At Spine Meetings 14
7.3.2 May 09, 2006: FzioMed Reports Promising Results Using Oxiplex Gel To Reduce Perivascular Adhesions In Preclinical Artificial Disc Surgery 14
8 FzioMed, Inc. Pipeline Products 16
8.1 FzioMed, Inc. Product Pipeline Analysis 16
8.1.1 FzioMed, Inc. Pipeline Products By Equipment Type 16
8.1.2 FzioMed, Inc. Pipeline Products By Development Stage 17
8.1.3 FzioMed, Inc. Pipeline Products By Therapy Area 17
8.1.4 FzioMed, Inc. Pipeline Products By Clinical Trials 18
8.1.5 FzioMed, Inc. Pipeline Products By News Summary 18
8.2 ETHICON Intercoat 19
8.2.1 Product Description 19
8.2.2 Product Status 19
8.3 MediShield 19
8.3.1 Product Description 19
8.3.2 Product Status 20
8.3.3 Product Milestone 20
8.4 Oxiplex 21
8.4.1 Product Description 21
8.4.2 Product Status 21
8.4.3 Clinical Trials 21
8.4.4 Product Milestone 23
9 Appendix 24
9.1 Methodology 24
9.1.1 Coverage 24
9.1.2 Secondary Research 25
9.1.3 Primary Research 25
9.1.4 Expert Panel Validation 26
9.2 Contact Us 26
9.3 About Global Markets Direct 26
9.4 Disclaimer 26

1.1 List of Tables
Table 1: FzioMed, Inc.,Key Facts 7
Table 2: FzioMed, Inc., Key Employees, 10
Table 3: FzioMed, Inc. Pipeline Products by Equipment Type 16
Table 4: FzioMed, Inc. Pipeline Products By Development Stage 17
Table 5: FzioMed, Inc. Pipeline Products By Therapy Area 17
Table 6: FzioMed, Inc. Pipeline Products By Clinical Trials 18
Table 7: FzioMed, Inc. Pipeline Products By News Summaries 18

1.2 List of Figures
Figure 1: FzioMed, Inc. Pipeline Products By Development Stage 17
Figure 2: FzioMed, Inc. Pipeline Products By News Summary 18
Figure 3: Global Markets Direct Methodology 24